Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kimberly L. Ostrow"'
Autor:
David Sidransky, Mohammad Obaidul Hoque, William H. Westra, Steven N. Goodman, Joseph A. Califano, André L. Carvalho, Marianna Zahurak, Kimberly L. Ostrow, Santanu Dasgupta, Mariana Brait, Shahnaz Begum
Purpose: We investigated the feasibility of detecting aberrant DNA methylation of some novel and known genes in the serum of lung cancer patients.Experimental Design: To determine the analytic sensitivity, we examined the tumor and the matched serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de1cee8badfc0a9e6e536f760208a8e
https://doi.org/10.1158/1078-0432.c.6519129
https://doi.org/10.1158/1078-0432.c.6519129
Autor:
David Sidransky, Mohammad Obaidul Hoque, William H. Westra, Steven N. Goodman, Joseph A. Califano, André L. Carvalho, Marianna Zahurak, Kimberly L. Ostrow, Santanu Dasgupta, Mariana Brait, Shahnaz Begum
Supplementary Figure S1; Supplementary Tables S1-S3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c2a19ecfc2e05b3310433676b5e480
https://doi.org/10.1158/1078-0432.22442394.v1
https://doi.org/10.1158/1078-0432.22442394.v1
Autor:
Ian M Smith, Chad A Glazer, Suhail K Mithani, Michael F Ochs, Wenyue Sun, Sheetal Bhan, Alexander Vostrov, Ziedulla Abdullaev, Victor Lobanenkov, Andrew Gray, Chunyan Liu, Steven S Chang, Kimberly L Ostrow, William H Westra, Shahnaz Begum, Mousumi Dhara, Joseph Califano
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4961 (2009)
Epigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by promoter demethylation have been sporadically reported. We used an integrative method to analyze expression in primary head and nec
Externí odkaz:
https://doaj.org/article/99162ff327134cfd85fe405bffd17c9c
Autor:
Alice S. Whittemore, Gail Gong, Esther M. John, Valerie McGuire, Frederick P. Li, Kimberly L. Ostrow, Richard DiCioccio, Anna Felberg, Dee W. West
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 13:2078-2083
Data from several countries indicate that 1% to 2% of Ashkenazi Jews carry a pathogenic ancestral mutation of the tumor suppressor gene BRCA1. However, the prevalence of BRCA1 mutations among non-Ashkenazi Whites is uncertain. We estimated mutation c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61b6001a29361a351e3f3555a3b5a30d
https://doi.org/10.1158/1055-9965.2078.13.12
https://doi.org/10.1158/1055-9965.2078.13.12